<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mounting evidence shows that <z:chebi fb="19" ids="27568">selenium</z:chebi> possesses chemotherapeutic potential against <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells, including <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:hpo ids='HP_0012125'>prostate cancer</z:hpo> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) cells </plain></SENT>
<SENT sid="1" pm="."><plain>However, the detailed mechanism by which <z:chebi fb="1" ids="48843">sodium selenite</z:chebi> specifically kills <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>Herein, we demonstrated that supranutritional doses of <z:chebi fb="2" ids="18212">selenite</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells through reactive oxygen species (ROS)-dependent modulation of the PI3K/AKT/FoxO3a signaling pathway </plain></SENT>
<SENT sid="3" pm="."><plain>First, we found that <z:chebi fb="2" ids="18212">selenite</z:chebi> treatment in HCT116 and SW480 <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells caused inhibition of AKT and the nuclear accumulation of FoxO3a by western blot and immunofluorescence analyses, respectively, thereby facilitating transcription of the target genes <z:chebi fb="3" ids="33173">bim</z:chebi> and PTEN </plain></SENT>
<SENT sid="4" pm="."><plain>Modulation of the AKT/FoxO3a/<z:chebi fb="3" ids="33173">Bim</z:chebi> signaling pathway by chemical inhibitors or <z:chebi fb="40" ids="33697">RNA</z:chebi> interference revealed that these events were critical for <z:chebi fb="2" ids="18212">selenite</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="5" pm="."><plain>Additionally, we discovered that FoxO3a-mediated upregulation of PTEN exerted a further inhibitory effect on the AKT survival pathway </plain></SENT>
<SENT sid="6" pm="."><plain>We also corroborated our findings in vivo by performing immunohistochemistry experiments </plain></SENT>
<SENT sid="7" pm="."><plain>In summary, our results show that <z:chebi fb="2" ids="18212">selenite</z:chebi> could induce ROS-dependent FoxO3a-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells and xenograft <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> through PTEN-mediated inhibition of the PI3K/AKT survival axis </plain></SENT>
<SENT sid="8" pm="."><plain>These results help to elucidate the molecular mechanisms underlying <z:chebi fb="2" ids="18212">selenite</z:chebi>-induced cell <z:hpo ids='HP_0011420'>death</z:hpo> in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells and provide a theoretical basis for translational applications of <z:chebi fb="19" ids="27568">selenium</z:chebi> </plain></SENT>
</text></document>